CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Open-label, Single-arm Study With Regard to the Efficacy and Safety of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04018365
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:17.451235+00:00
Published At: 2021-03-03T00:00:00+00:00
Record Updated At: 2021-03-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Insulin Resistance - Type A", "Insulin Resistance - Type B", "Lipoatrophic Diabetes Mellitus", "Insulin Resistance Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-03-03"
protocolSection.identificationModule.nctId: "NCT04018365"
protocolSection.identificationModule.officialTitle: "A Multicenter, Open-label, Single-arm Study With Regard to the Efficacy and Safety of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.